Aixin Life files financial statements for acquired pharmacies; shows 2020 net loss of $185K

AiXin Life International, Inc.

Acquired entity Chengdu Aixintang Pharmacy (9 pharmacies) had 2020 revenue of $1.26M and net loss of $185K.
Accumulated deficit at Dec 2020 was $1.19M; stockholders' deficit of $987K.
Pro forma financials also include hotel entity from a separate May 2021 acquisition.
Amendment corrects prior 8-K which misstated the acquired entity's name.
Audited and unaudited combined financials now filed for years ended 2020/2019 and Q1 2021.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.